Evidence map›Paper›PMID 39874347›Full record

ArticlePloS one2025

A clinical study exploring the prediction of microvascular invasion in hepatocellular carcinoma through the use of combined enhanced CT and MRI radiomics.

Jiangfa Li, Wenxiang Song, Jixue Li, Lv Cai, Zhao Jiang, Mengxiao Wei, Boming Nong, Meiyu Lai, Yiyi Jiang, Erbo Zhao and 1 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiangfa LiDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.ORCID 0000-0003-4043-0526
Wenxiang SongDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Jixue LiDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Lv CaiDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Zhao JiangDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Mengxiao WeiDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Boming NongDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Meiyu LaiDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Yiyi JiangDepartment of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Erbo ZhaoDepartment of Information, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Liping LeiDepartment of Geriatric Medicine, the Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop a predictive model for microvascular invasion (MVI) in hepatocellular carcinoma (HCC) through radiomics analysis, integrating data from both enhanced computed tomography (CT) and magnetic resonance imaging (MRI).

methodsA retrospective analysis was conducted on 93 HCC patients who underwent partial hepatectomy. The gold standard for MVI was based on the histopathological diagnosis of the tissue. The 93 patients were randomly divided into training and validation groups in 7:3 ratio. The imaging data of patients, including CT and MRI, were collected and processed using 3D Slicer to delineate the region of interest (ROI) for each tumor. Radiomics features were extracted from CT and MRI of patients using Python. Lasso regression analysis was used to select optimal radiomics features for MVI in the training group. The optimal radiomics features of CT and MRI were selected to establish the prediction model. The predictive performance of the model was evaluated using the receiver operator characteristic curve (ROC), calibration curve, and decision curve analysis (DCA).

resultsAfter univariate and multivariate analyses, it was found that tumor diameter was significantly different between the MVI positive and negative groups. After extracting 2153 imaging phenotyping features from the CT and MRI images of the 93 patients using Python, ten standardized coefficient non-zero imaging phenotyping features were finally determined by Lasso regression analysis in the CT and MRI images. A comprehensive predictive model with clinical variable and optimal radiomics features was established. The area under the curve (AUC) of the training group was 0.916 (95%CI: 0.843-1.000), sensitivity: 95.2%, specificity: 79.2%. In the validation group, the predictive model diagnosed MVI with AUC = 0.816 (95%CI: 0.642-0.990), sensitivity: 84.2%, and specificity: 75.0%.

conclusionThe joint model that integrated the optimal radiomics features with clinical variables has good diagnostic performance for MVI of HCC and specific clinical applicability.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMagnetic Resonance ImagingMicrovesselsTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedNeoplasm InvasivenessRadiomicsRetrospective StudiesROC Curve

Identifiers

PMID39874347
PMCPMC11774365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.